Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models
出版年份 2019 全文链接
标题
Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 2, Pages 942-957
出版商
American Society for Clinical Investigation
发表日期
2019-11-06
DOI
10.1172/jci127425
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model
- (2019) Angela M. Crist et al. CIRCULATION
- Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia
- (2018) Angela M. Crist et al. ANGIOGENESIS
- ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K ActivationHighlights
- (2018) Elisenda Alsina-Sanchís et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- SMAD4 Prevents Flow Induced Arterial-Venous Malformations by Inhibiting Casein Kinase 2
- (2018) Roxana Ola et al. CIRCULATION
- Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
- (2018) Vivek N. Iyer et al. MAYO CLINIC PROCEEDINGS
- FYN KYNASE IS A NOVEL MODULATOR OF ERYTHROPOIETIN SIGNALING AND STRESS ERYTHROPOIESIS
- (2018) Elisabetta Beneduce et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
- (2018) Marie E. Faughnan et al. ANGIOGENESIS
- Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2
- (2018) Jérémy H. Thalgott et al. CIRCULATION
- Recurrence of hereditary hemorrhagic telangiectasia after liver transplantation: clinical implications and physiopathological insights
- (2018) Jérôme Dumortier et al. HEPATOLOGY
- Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
- (2018) Veronique Vorselaars et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SMAD4 Deficiency Leads to Development of Arteriovenous Malformations in Neonatal and Adult Mice
- (2018) Yong Hwan Kim et al. Journal of the American Heart Association
- Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia
- (2017) Lidia Ruiz-Llorente et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology
- (2017) Santiago Ruiz et al. HUMAN MOLECULAR GENETICS
- Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia
- (2017) Y. H. Kim et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling
- (2017) Yi Jin et al. NATURE CELL BIOLOGY
- Bone Morphogenetic Proteins in Vascular Homeostasis and Disease
- (2017) Marie-José Goumans et al. Cold Spring Harbor Perspectives in Biology
- Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1
- (2017) Takako Saito et al. Cell Reports
- Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
- (2017) Alexandre Guilhem et al. PLoS One
- Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
- (2016) D. M. Adams et al. PEDIATRICS
- PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia
- (2016) Roxana Ola et al. Nature Communications
- Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension
- (2015) Edda Spiekerkoetter et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia
- (2015) Ferdos Alaa el Din et al. PLoS One
- Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
- (2015) Daniela S. Ardelean et al. Frontiers in Genetics
- Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges
- (2015) Simon Tual-Chalot et al. Frontiers in Genetics
- Common and Distinctive Pathogenetic Features of Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia 1 and Hereditary Hemorrhagic Telangiectasia 2 Animal Models—Brief Report
- (2014) Eva M. Garrido-Martin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function
- (2014) C. Mallet et al. HUMAN MOLECULAR GENETICS
- Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression
- (2014) Simon Tual-Chalot et al. PLoS One
- BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia
- (2013) Whitney L. Wooderchak-Donahue et al. AMERICAN JOURNAL OF HUMAN GENETICS
- FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
- (2013) Edda Spiekerkoetter et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced Responses to Angiogenic Cues Underlie the Pathogenesis of Hereditary Hemorrhagic Telangiectasia 2
- (2013) Eun-Jung Choi et al. PLoS One
- BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II
- (2012) Jai-Hyun Kim et al. ANGIOGENESIS
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- BMP signaling in vascular diseases
- (2012) Jie Cai et al. FEBS LETTERS
- TGFβ signalling in context
- (2012) Joan Massagué NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interaction between alk1 and blood flow in the development of arteriovenous malformations
- (2011) P. Corti et al. DEVELOPMENT
- Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor- 1 Signaling in Endothelial Cells
- (2011) V. Albinana et al. MOLECULAR PHARMACOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- PI3K/AKT/mTOR Pathway in Angiogenesis
- (2011) Jayashree Karar et al. Frontiers in Molecular Neuroscience
- Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations
- (2010) N. Ricard et al. BLOOD
- Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
- (2010) Claire L. Shovlin BLOOD REVIEWS
- Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin
- (2010) Marwa Mahmoud et al. CIRCULATION RESEARCH
- Hereditary hemorrhagic telangiectasia: from molecular biology to patient care
- (2010) S. DUPUIS-GIROD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia
- (2010) Franck Lebrin et al. NATURE MEDICINE
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
- (2010) David Warde-Farley et al. NUCLEIC ACIDS RESEARCH
- Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia
- (2009) Sung Ok Park et al. JOURNAL OF CLINICAL INVESTIGATION
- International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
- (2009) M. E. Faughnan et al. JOURNAL OF MEDICAL GENETICS
- Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis
- (2009) K. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva
- (2008) Toru Fukuda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2
- (2007) S. O. Park et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now